2024 Q3 Form 10-Q Financial Statement
#000149315224030835 Filed on August 08, 2024
Income Statement
Concept | 2024 Q3 | 2024 Q2 |
---|---|---|
Revenue | $206.0K | $234.3K |
YoY Change | -74.22% | -50.51% |
Cost Of Revenue | $8.317M | $8.685M |
YoY Change | 45.99% | 31.12% |
Gross Profit | $5.003M | $3.651M |
YoY Change | 5.04% | -11.68% |
Gross Profit Margin | 2428.69% | 1558.14% |
Selling, General & Admin | $5.207M | $7.268M |
YoY Change | -19.47% | 56.36% |
% of Gross Profit | 104.08% | 199.06% |
Research & Development | $2.597M | $1.840M |
YoY Change | -17.1% | -20.44% |
% of Gross Profit | 51.9% | 50.39% |
Depreciation & Amortization | $138.5K | $136.8K |
YoY Change | -15.16% | -39.1% |
% of Gross Profit | 2.77% | 3.75% |
Operating Expenses | $16.12M | $17.79M |
YoY Change | 5.39% | 30.98% |
Operating Profit | -$2.801M | -$5.456M |
YoY Change | -42.08% | 93.06% |
Interest Expense | -$540.7K | -$484.4K |
YoY Change | -83.82% | -342.62% |
% of Operating Profit | ||
Other Income/Expense, Net | -$534.5K | -$465.6K |
YoY Change | -83.83% | -296.69% |
Pretax Income | -$3.335M | -$5.922M |
YoY Change | -59.03% | 128.69% |
Income Tax | $125.0K | |
% Of Pretax Income | ||
Net Earnings | -$3.460M | -$5.922M |
YoY Change | -57.7% | 125.29% |
Net Earnings / Revenue | -1679.91% | -2527.28% |
Basic Earnings Per Share | -$0.03 | -$0.05 |
Diluted Earnings Per Share | -$0.03 | -$0.05 |
COMMON SHARES | ||
Basic Shares Outstanding | 121.0M shares | 118.4M shares |
Diluted Shares Outstanding | 124.3M shares | 121.4M shares |
Balance Sheet
Concept | 2024 Q3 | 2024 Q2 |
---|---|---|
SHORT-TERM ASSETS | ||
Cash & Short-Term Investments | $36.24M | $17.63M |
YoY Change | 41.19% | -40.46% |
Cash & Equivalents | $14.53M | $10.04M |
Short-Term Investments | $21.71M | $7.587M |
Other Short-Term Assets | $2.697M | $3.111M |
YoY Change | 28.8% | 81.74% |
Inventory | $6.555M | $5.650M |
Prepaid Expenses | ||
Receivables | $9.234M | $7.406M |
Other Receivables | $0.00 | $0.00 |
Total Short-Term Assets | $63.00M | $40.32M |
YoY Change | 37.2% | -13.84% |
LONG-TERM ASSETS | ||
Property, Plant & Equipment | $2.016M | $2.143M |
YoY Change | 12.0% | 17.37% |
Goodwill | ||
YoY Change | ||
Intangibles | ||
YoY Change | ||
Long-Term Investments | $3.129M | $3.982M |
YoY Change | -32.35% | -48.47% |
Other Assets | $124.9K | $124.9K |
YoY Change | -26.14% | -26.14% |
Total Long-Term Assets | $7.576M | $8.728M |
YoY Change | -19.77% | -31.43% |
TOTAL ASSETS | ||
Total Short-Term Assets | $63.00M | $40.32M |
Total Long-Term Assets | $7.576M | $8.728M |
Total Assets | $70.58M | $49.05M |
YoY Change | 27.48% | -17.6% |
SHORT-TERM LIABILITIES | ||
YoY Change | ||
Accounts Payable | $4.386M | $5.714M |
YoY Change | -32.6% | 48.93% |
Accrued Expenses | $13.69M | $13.42M |
YoY Change | 110.13% | 129.22% |
Deferred Revenue | $268.5K | $198.3K |
YoY Change | -51.62% | -72.4% |
Short-Term Debt | $0.00 | $0.00 |
YoY Change | ||
Long-Term Debt Due | ||
YoY Change | ||
Total Short-Term Liabilities | $43.95M | $45.35M |
YoY Change | 194.76% | 285.86% |
LONG-TERM LIABILITIES | ||
Long-Term Debt | $0.00 | $0.00 |
YoY Change | ||
Other Long-Term Liabilities | $1.619M | $1.494M |
YoY Change | 16.42% | 9.76% |
Total Long-Term Liabilities | $1.619M | $1.494M |
YoY Change | 16.42% | 9.76% |
TOTAL LIABILITIES | ||
Total Short-Term Liabilities | $43.95M | $45.35M |
Total Long-Term Liabilities | $1.619M | $1.494M |
Total Liabilities | $47.85M | $49.26M |
YoY Change | 146.18% | 196.29% |
SHAREHOLDERS EQUITY | ||
Retained Earnings | -$400.1M | -$396.6M |
YoY Change | 14.57% | 16.3% |
Common Stock | $1.533M | $1.156M |
YoY Change | 38.85% | 5.16% |
Preferred Stock | ||
YoY Change | ||
Treasury Stock (at cost) | $103.2K | $103.1K |
YoY Change | 0.05% | 0.0% |
Treasury Stock Shares | ||
Shareholders Equity | $22.73M | -$216.3K |
YoY Change | ||
Total Liabilities & Shareholders Equity | $70.58M | $49.05M |
YoY Change | 27.48% | -17.6% |
Cashflow Statement
Concept | 2024 Q3 | 2024 Q2 |
---|---|---|
OPERATING ACTIVITIES | ||
Net Income | -$3.460M | -$5.922M |
YoY Change | -57.7% | 125.29% |
Depreciation, Depletion And Amortization | $138.5K | $136.8K |
YoY Change | -15.16% | -39.1% |
Cash From Operating Activities | -$6.457M | -$3.077M |
YoY Change | 69.13% | -26.29% |
INVESTING ACTIVITIES | ||
Capital Expenditures | $10.27K | $65.17K |
YoY Change | -92.34% | -69.91% |
Acquisitions | ||
YoY Change | ||
Other Investing Activities | -$14.24M | -$639.0K |
YoY Change | -360.62% | 63800.0% |
Cash From Investing Activities | -$14.25M | -$704.2K |
YoY Change | -367.37% | -95.82% |
FINANCING ACTIVITIES | ||
Cash Dividend Paid | ||
YoY Change | ||
Common Stock Issuance & Retirement, Net | ||
YoY Change | ||
Debt Paid & Issued, Net | ||
YoY Change | ||
Cash From Financing Activities | 25.20M | 0.000 |
YoY Change | -100.0% | |
NET CHANGE | ||
Cash From Operating Activities | -6.457M | -3.077M |
Cash From Investing Activities | -14.25M | -704.2K |
Cash From Financing Activities | 25.20M | 0.000 |
Net Change In Cash | 4.486M | -3.781M |
YoY Change | 196.31% | -1266.05% |
FREE CASH FLOW | ||
Cash From Operating Activities | -$6.457M | -$3.077M |
Capital Expenditures | $10.27K | $65.17K |
Free Cash Flow | -$6.467M | -$3.142M |
YoY Change | 63.66% | -28.44% |
Facts In Submission
Frame | Concept Type | Concept / XBRL Key | Value | Unit |
---|---|---|---|---|
CY2024Q2 | us-gaap |
Income Tax Expense Benefit
IncomeTaxExpenseBenefit
|
usd | |
us-gaap |
Income Tax Expense Benefit
IncomeTaxExpenseBenefit
|
usd | ||
CY2023Q2 | us-gaap |
Stock Issued During Period Value Restricted Stock Award Net Of Forfeitures
StockIssuedDuringPeriodValueRestrictedStockAwardNetOfForfeitures
|
usd | |
CY2023Q2 | us-gaap |
Noncontrolling Interest Increase From Business Combination
NoncontrollingInterestIncreaseFromBusinessCombination
|
usd | |
CY2023Q3 | us-gaap |
Stock Issued During Period Value Restricted Stock Award Net Of Forfeitures
StockIssuedDuringPeriodValueRestrictedStockAwardNetOfForfeitures
|
usd | |
us-gaap |
Deferred Other Tax Expense Benefit
DeferredOtherTaxExpenseBenefit
|
usd | ||
KOPN |
Increase Decrease In Provision For Credit Losses
IncreaseDecreaseInProvisionForCreditLosses
|
usd | ||
KOPN |
Increase Decrease In Accrued Litigation Damages
IncreaseDecreaseInAccruedLitigationDamages
|
usd | ||
us-gaap |
Payments For Proceeds From Other Investing Activities
PaymentsForProceedsFromOtherInvestingActivities
|
usd | ||
KOPN |
Issuance Of Common Stock Net Of Costs
IssuanceOfCommonStockNetOfCosts
|
usd | ||
us-gaap |
Proceeds From Issuance Of Common Stock
ProceedsFromIssuanceOfCommonStock
|
usd | ||
us-gaap |
Financing Receivable Allowance For Credit Losses Recovery
FinancingReceivableAllowanceForCreditLossesRecovery
|
usd | ||
CY2023Q3 | us-gaap |
Gain Loss On Investments
GainLossOnInvestments
|
-3327347 | usd |
CY2022Q4 | us-gaap |
Stockholders Equity Including Portion Attributable To Noncontrolling Interest
StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest
|
23990615 | usd |
CY2023Q2 | us-gaap |
Adjustments To Additional Paid In Capital Sharebased Compensation Requisite Service Period Recognition Value
AdjustmentsToAdditionalPaidInCapitalSharebasedCompensationRequisiteServicePeriodRecognitionValue
|
194190 | usd |
CY2023Q2 | us-gaap |
Other Comprehensive Income Loss Net Of Tax
OtherComprehensiveIncomeLossNetOfTax
|
6227 | usd |
CY2023Q2 | us-gaap |
Stock Issued During Period Value New Issues
StockIssuedDuringPeriodValueNewIssues
|
21335000 | usd |
CY2023Q2 | us-gaap |
Stock Issued During Period Value New Issues
StockIssuedDuringPeriodValueNewIssues
|
21335000 | usd |
CY2023Q2 | us-gaap |
Profit Loss
ProfitLoss
|
-2628555 | usd |
CY2023Q2 | us-gaap |
Stockholders Equity Including Portion Attributable To Noncontrolling Interest
StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest
|
42897477 | usd |
CY2023Q2 | us-gaap |
Stockholders Equity Including Portion Attributable To Noncontrolling Interest
StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest
|
42897477 | usd |
CY2023Q3 | us-gaap |
Adjustments To Additional Paid In Capital Sharebased Compensation Requisite Service Period Recognition Value
AdjustmentsToAdditionalPaidInCapitalSharebasedCompensationRequisiteServicePeriodRecognitionValue
|
1191257 | usd |
CY2023Q3 | us-gaap |
Other Comprehensive Income Loss Net Of Tax
OtherComprehensiveIncomeLossNetOfTax
|
17750 | usd |
CY2023Q3 | us-gaap |
Profit Loss
ProfitLoss
|
-8180379 | usd |
CY2023Q3 | us-gaap |
Stockholders Equity Including Portion Attributable To Noncontrolling Interest
StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest
|
35926105 | usd |
CY2023Q3 | us-gaap |
Stockholders Equity Including Portion Attributable To Noncontrolling Interest
StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest
|
35926105 | usd |
us-gaap |
Profit Loss
ProfitLoss
|
-38470213 | usd | |
us-gaap |
Profit Loss
ProfitLoss
|
-10808934 | usd | |
us-gaap |
Depreciation And Amortization
DepreciationAndAmortization
|
332155 | usd | |
us-gaap |
Depreciation And Amortization
DepreciationAndAmortization
|
387779 | usd | |
us-gaap |
Share Based Compensation
ShareBasedCompensation
|
1411346 | usd | |
us-gaap |
Share Based Compensation
ShareBasedCompensation
|
1385449 | usd | |
us-gaap |
Deferred Other Tax Expense Benefit
DeferredOtherTaxExpenseBenefit
|
78210 | usd | |
us-gaap |
Foreign Currency Transaction Gain Loss Before Tax
ForeignCurrencyTransactionGainLossBeforeTax
|
-38633 | usd | |
us-gaap |
Foreign Currency Transaction Gain Loss Before Tax
ForeignCurrencyTransactionGainLossBeforeTax
|
-51950 | usd | |
KOPN |
Increase Decrease In Provision For Credit Losses
IncreaseDecreaseInProvisionForCreditLosses
|
790950 | usd | |
KOPN |
Noncash Provision For Excess Inventory
NoncashProvisionForExcessInventory
|
1023709 | usd | |
KOPN |
Noncash Provision For Excess Inventory
NoncashProvisionForExcessInventory
|
292405 | usd | |
us-gaap |
Other Asset Impairment Charges
OtherAssetImpairmentCharges
|
734243 | usd | |
us-gaap |
Other Asset Impairment Charges
OtherAssetImpairmentCharges
|
2887893 | usd | |
us-gaap |
Other Noncash Income Expense
OtherNoncashIncomeExpense
|
-513556 | usd | |
us-gaap |
Other Noncash Income Expense
OtherNoncashIncomeExpense
|
-198194 | usd | |
us-gaap |
Increase Decrease In Accounts Receivable
IncreaseDecreaseInAccountsReceivable
|
-2994914 | usd | |
us-gaap |
Increase Decrease In Accounts Receivable
IncreaseDecreaseInAccountsReceivable
|
1565340 | usd | |
us-gaap |
Increase Decrease In Contract With Customer Asset
IncreaseDecreaseInContractWithCustomerAsset
|
3353456 | usd | |
us-gaap |
Increase Decrease In Contract With Customer Asset
IncreaseDecreaseInContractWithCustomerAsset
|
96923 | usd | |
us-gaap |
Increase Decrease In Inventories
IncreaseDecreaseInInventories
|
-912158 | usd | |
us-gaap |
Increase Decrease In Inventories
IncreaseDecreaseInInventories
|
1685961 | usd | |
us-gaap |
Increase Decrease In Prepaid Deferred Expense And Other Assets
IncreaseDecreaseInPrepaidDeferredExpenseAndOtherAssets
|
857448 | usd | |
us-gaap |
Increase Decrease In Prepaid Deferred Expense And Other Assets
IncreaseDecreaseInPrepaidDeferredExpenseAndOtherAssets
|
929086 | usd | |
us-gaap |
Increase Decrease In Accounts Payable And Accrued Liabilities
IncreaseDecreaseInAccountsPayableAndAccruedLiabilities
|
4474548 | usd | |
us-gaap |
Increase Decrease In Accounts Payable And Accrued Liabilities
IncreaseDecreaseInAccountsPayableAndAccruedLiabilities
|
1396840 | usd | |
us-gaap |
Increase Decrease In Contract With Customer Liability
IncreaseDecreaseInContractWithCustomerLiability
|
-738047 | usd | |
us-gaap |
Increase Decrease In Contract With Customer Liability
IncreaseDecreaseInContractWithCustomerLiability
|
-375499 | usd | |
KOPN |
Increase Decrease In Accrued Litigation Damages
IncreaseDecreaseInAccruedLitigationDamages
|
24800000 | usd | |
us-gaap |
Net Cash Provided By Used In Operating Activities
NetCashProvidedByUsedInOperatingActivities
|
-6183902 | usd | |
us-gaap |
Net Cash Provided By Used In Operating Activities
NetCashProvidedByUsedInOperatingActivities
|
-7992073 | usd | |
us-gaap |
Payments To Acquire Property Plant And Equipment
PaymentsToAcquirePropertyPlantAndEquipment
|
310600 | usd | |
us-gaap |
Payments To Acquire Property Plant And Equipment
PaymentsToAcquirePropertyPlantAndEquipment
|
350631 | usd | |
us-gaap |
Payments To Acquire Marketable Securities
PaymentsToAcquireMarketableSecurities
|
1119012 | usd | |
us-gaap |
Payments To Acquire Marketable Securities
PaymentsToAcquireMarketableSecurities
|
17624779 | usd | |
us-gaap |
Proceeds From Sale Of Available For Sale Securities Debt
ProceedsFromSaleOfAvailableForSaleSecuritiesDebt
|
5250066 | usd | |
us-gaap |
Proceeds From Sale Of Available For Sale Securities Debt
ProceedsFromSaleOfAvailableForSaleSecuritiesDebt
|
6466917 | usd | |
us-gaap |
Payments For Proceeds From Other Investing Activities
PaymentsForProceedsFromOtherInvestingActivities
|
483 | usd | |
us-gaap |
Net Cash Provided By Used In Investing Activities
NetCashProvidedByUsedInInvestingActivities
|
3820454 | usd | |
us-gaap |
Net Cash Provided By Used In Investing Activities
NetCashProvidedByUsedInInvestingActivities
|
-11508976 | usd | |
KOPN |
Issuance Of Common Stock Net Of Costs
IssuanceOfCommonStockNetOfCosts
|
7242581 | usd | |
us-gaap |
Proceeds From Issuance Of Common Stock
ProceedsFromIssuanceOfCommonStock
|
21335000 | usd | |
us-gaap |
Net Cash Provided By Used In Financing Activities
NetCashProvidedByUsedInFinancingActivities
|
7242581 | usd | |
us-gaap |
Net Cash Provided By Used In Financing Activities
NetCashProvidedByUsedInFinancingActivities
|
21335000 | usd | |
us-gaap |
Effect Of Exchange Rate On Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents Including Disposal Group And Discontinued Operations
EffectOfExchangeRateOnCashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsIncludingDisposalGroupAndDiscontinuedOperations
|
3029 | usd | |
us-gaap |
Effect Of Exchange Rate On Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents Including Disposal Group And Discontinued Operations
EffectOfExchangeRateOnCashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsIncludingDisposalGroupAndDiscontinuedOperations
|
13839 | usd | |
us-gaap |
Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents Period Increase Decrease Including Exchange Rate Effect
CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsPeriodIncreaseDecreaseIncludingExchangeRateEffect
|
4882162 | usd | |
us-gaap |
Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents Period Increase Decrease Including Exchange Rate Effect
CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsPeriodIncreaseDecreaseIncludingExchangeRateEffect
|
1847790 | usd | |
CY2023Q4 | us-gaap |
Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents Including Disposal Group And Discontinued Operations
CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsIncludingDisposalGroupAndDiscontinuedOperations
|
6210685 | usd |
CY2022Q4 | us-gaap |
Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents Including Disposal Group And Discontinued Operations
CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsIncludingDisposalGroupAndDiscontinuedOperations
|
8258878 | usd |
CY2024Q2 | us-gaap |
Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents Including Disposal Group And Discontinued Operations
CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsIncludingDisposalGroupAndDiscontinuedOperations
|
11092847 | usd |
CY2023Q3 | us-gaap |
Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents Including Disposal Group And Discontinued Operations
CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsIncludingDisposalGroupAndDiscontinuedOperations
|
10106668 | usd |
us-gaap |
Basis Of Accounting
BasisOfAccounting
|
<p id="xdx_804_eus-gaap--BasisOfAccounting_zuFFtOpvv049" style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b>1. <span id="xdx_82E_zLNpBNTP5T3">BASIS OF PRESENTATION</span></b></span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 22.5pt; text-align: justify; text-indent: -22.5pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; text-indent: 0.25in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">The condensed consolidated financial statements of Kopin Corporation as of June 29, 2024 and for the three and six month periods ended June 29, 2024 and July 1, 2023 are unaudited and include all adjustments that, in the opinion of management, are necessary to present fairly the results of operations for the periods then ended. These condensed consolidated financial statements should be read in conjunction with the Company’s financial statements and notes thereto, included in the Company’s Annual Report on Form 10-K for the fiscal year ended December 30, 2023. The results of the Company’s operations for any interim period are not necessarily indicative of the results of the Company’s operations for any other interim period or for a full fiscal year. As used in this report, the terms “we”, “us”, “our”, “Kopin” and the “Company” mean Kopin Corporation and its subsidiaries, unless the context indicates another meaning.</span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; text-indent: 22.5pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; text-indent: 0.25in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">The condensed consolidated financial statements for the three and six month periods ended June 29, 2024 and July 1, 2023 include the accounts of Kopin Corporation and its wholly owned subsidiaries. All intercompany transactions and balances have been eliminated.</span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; text-indent: 0.25in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><i>Going Concern</i></span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><i> </i></span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; text-indent: 0.25in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">The accompanying consolidated financial statements have been prepared on a going concern basis, which contemplates the realization of assets and the satisfaction of liabilities in the normal course of business. The Company incurred a net loss of $<span id="xdx_905_eus-gaap--NetIncomeLoss_iN_pn5n6_di_c20230101__20231230_z51Mmdfg7bYi" title="Net losses">19.7</span> million and net cash outflows from operations of $<span id="xdx_902_eus-gaap--NetCashProvidedByUsedInOperatingActivities_iN_pn5n6_di_c20230101__20231230_z771w8J06pp7" title="Net cash outflows from operations">15.3</span> million for the fiscal year ended 2023. The Company incurred a net loss of $<span id="xdx_908_eus-gaap--NetIncomeLoss_iN_pn5n6_di_c20231231__20240629_zWKl8PSskC0e" title="Net losses">38.5</span> million for the six months ended June 29, 2024 and net cash outflows from operations of $<span id="xdx_909_eus-gaap--NetCashProvidedByUsedInOperatingActivities_iN_pn5n6_di_c20231231__20240629_zE127hZNPTM5" title="Net cash outflows from operations">6.2</span> million. This net loss of $<span id="xdx_90E_eus-gaap--NetIncomeLoss_iN_pn5n6_di_c20231231__20240629_zBvMT0fp9fAf" title="Net losses">38.5</span> million includes an estimated $<span id="xdx_905_ecustom--EstimatedPossibleDamagesAmount_pn5n6_c20231231__20240629_zBuq3jSC2sYi" title="Estimated possible damages amount">24.8</span> million of possible damages related to a jury verdict which is explained below. In addition, the Company has experienced a significant decline in its cash and cash equivalents and marketable debt securities over the last several years, which was primarily a result of funding operating losses. As described in Note 14 Litigation, on April 22, 2024, a jury verdict was entered against the Company awarding approximately $<span id="xdx_90D_eus-gaap--LitigationSettlementLoss_pn5n6_c20240422__20240422_z5jfnbpCSpM2" title="Damages settlement">5.1</span> million in damages as well as recommending $<span id="xdx_908_eus-gaap--PaymentsForLegalSettlements_pn5n6_c20240422__20240422_zvTj3KYs7cLg" title="Exemplary damages">19.7</span> million in disgorgement and exemplary damages. On May 22, 2024, the Company filed its Motion for Judgment as a Matter of Law or in the alternative for a New Trial, as well as two submissions arguing that the disgorgement and exemplary damages should not be awarded. That same day, BlueRadios filed motions seeking a permanent injunction prohibiting Kopin from selling any products that incorporate BlueRadios’ trade secrets, over $<span id="xdx_907_eus-gaap--PrepaidInterest_iI_pn6n6_c20240522_zUHT8LM4LDzf" title="Pre-judgment interest">10</span> million in pre-judgment interest, and over $<span id="xdx_90B_eus-gaap--LegalFees_pn6n6_c20240522__20240522_zsYfICvpGnW4" title="Attorneys fees and costs">10</span> million in attorneys’ fees and costs. While no final judgment has been issued by the Court, the Court will take that recommendation under advisement and will rule in its final judgment on the final amount after briefing on the issues. The Company is also considering the appeal of any award in a final judgment. The Company had $<span id="xdx_902_eus-gaap--CashCashEquivalentsAndShortTermInvestments_iI_pn5n6_c20240629_zdqcRGNrMX4a" title="Cash and cash equivalents, restricted cash, and marketable debt securities">18.7</span> million of cash and cash equivalents, restricted cash, and marketable debt securities at June 29, 2024.</span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; text-indent: 0.25in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; text-indent: 24pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">The Company has historical and current negative cash flow from operations and limited liquidity resources. The Company’s current strategy is to continue to invest in its business and raise additional capital through financing activities that may include public offerings and private placements of its common stock, preferred stock offerings, collaborations and licensing arrangements and issuances of debt and convertible debt instruments. Until such time that additional capital can be raised, the Company plans to strategically manage its uncommitted spend, execute its priorities and implement cost saving measures to reduce research and development and general and administrative expenditures which could include minimizing staff costs. The Company may also sell assets and look at other strategic alternatives. There are inherent uncertainties associated with fundraising activities and activities to manage our uncommitted spending and the successful execution of these activities may not be within the Company’s control. There are no assurances that such additional funding will be obtained and that the Company will succeed in its future operations. If the Company is unable to achieve positive cash flows and profitability in the foreseeable future, cannot successfully raise additional capital and implement its strategic plan, or the recommended disgorgement and exemplary damages are not significantly reduced or eliminated in the final order, the Company’s liquidity, financial condition and business prospects will be materially and adversely affected. There is substantial doubt about the Company’s ability to continue as a going concern.</span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></p> | ||
CY2023 | us-gaap |
Net Income Loss
NetIncomeLoss
|
-19700000 | usd |
CY2023 | us-gaap |
Net Cash Provided By Used In Operating Activities
NetCashProvidedByUsedInOperatingActivities
|
-15300000 | usd |
us-gaap |
Net Income Loss
NetIncomeLoss
|
-38500000 | usd | |
us-gaap |
Net Cash Provided By Used In Operating Activities
NetCashProvidedByUsedInOperatingActivities
|
-6200000 | usd | |
us-gaap |
Net Income Loss
NetIncomeLoss
|
-38500000 | usd | |
KOPN |
Estimated Possible Damages Amount
EstimatedPossibleDamagesAmount
|
24800000 | usd | |
CY2024Q2 | us-gaap |
Litigation Settlement Loss
LitigationSettlementLoss
|
5100000 | usd |
CY2024Q2 | us-gaap |
Payments For Legal Settlements
PaymentsForLegalSettlements
|
19700000 | usd |
CY2024Q2 | us-gaap |
Prepaid Interest
PrepaidInterest
|
10000000 | usd |
CY2024Q2 | us-gaap |
Legal Fees
LegalFees
|
10000000 | usd |
CY2024Q2 | us-gaap |
Cash Cash Equivalents And Short Term Investments
CashCashEquivalentsAndShortTermInvestments
|
18700000 | usd |
CY2024Q2 | us-gaap |
Restricted Cash Current
RestrictedCashCurrent
|
1100000 | usd |
CY2024Q2 | us-gaap |
Available For Sale Debt Securities Amortized Cost Basis
AvailableForSaleDebtSecuritiesAmortizedCostBasis
|
8119150 | usd |
CY2023Q4 | us-gaap |
Available For Sale Debt Securities Amortized Cost Basis
AvailableForSaleDebtSecuritiesAmortizedCostBasis
|
12250204 | usd |
CY2024Q2 | us-gaap |
Debt Securities Available For Sale Accumulated Gross Unrealized Gain Loss Before Tax
DebtSecuritiesAvailableForSaleAccumulatedGrossUnrealizedGainLossBeforeTax
|
-32136 | usd |
CY2023Q4 | us-gaap |
Debt Securities Available For Sale Accumulated Gross Unrealized Gain Loss Before Tax
DebtSecuritiesAvailableForSaleAccumulatedGrossUnrealizedGainLossBeforeTax
|
-58204 | usd |
CY2024Q2 | us-gaap |
Available For Sale Securities Debt Securities
AvailableForSaleSecuritiesDebtSecurities
|
8087014 | usd |
CY2023Q4 | us-gaap |
Available For Sale Securities Debt Securities
AvailableForSaleSecuritiesDebtSecurities
|
12192000 | usd |
CY2024Q2 | us-gaap |
Available For Sale Securities Debt Maturities Within One Year Fair Value
AvailableForSaleSecuritiesDebtMaturitiesWithinOneYearFairValue
|
7120181 | usd |
CY2024Q2 | us-gaap |
Available For Sale Securities Debt Maturities After One Through Five Years Fair Value
AvailableForSaleSecuritiesDebtMaturitiesAfterOneThroughFiveYearsFairValue
|
966833 | usd |
CY2024Q2 | us-gaap |
Available For Sale Securities Debt Securities
AvailableForSaleSecuritiesDebtSecurities
|
8087014 | usd |
CY2024Q2 | us-gaap |
Financial Instruments Owned At Fair Value
FinancialInstrumentsOwnedAtFairValue
|
18892823 | usd |
CY2023Q4 | us-gaap |
Financial Instruments Owned At Fair Value
FinancialInstrumentsOwnedAtFairValue
|
21960127 | usd |
CY2024Q2 | us-gaap |
Investments
Investments
|
5200000 | usd |
CY2023Q3 | us-gaap |
Payments For Royalties
PaymentsForRoyalties
|
400000 | usd |
CY2023Q3 | us-gaap |
Asset Impairment Charges
AssetImpairmentCharges
|
3100000 | usd |
CY2023Q3 | us-gaap |
Increase Decrease In Receivable For Investment Sold
IncreaseDecreaseInReceivableForInvestmentSold
|
2500000 | usd |
CY2024Q2 | us-gaap |
Asset Impairment Charges
AssetImpairmentCharges
|
700000 | usd |
CY2024Q2 | us-gaap |
Increase Decrease In Receivable For Investment Sold
IncreaseDecreaseInReceivableForInvestmentSold
|
1800000 | usd |
CY2024Q2 | us-gaap |
Other Investments
OtherInvestments
|
2000000.0 | usd |
CY2024Q2 | us-gaap |
Accounts Receivable Gross Current
AccountsReceivableGrossCurrent
|
8394272 | usd |
CY2023Q4 | us-gaap |
Accounts Receivable Gross Current
AccountsReceivableGrossCurrent
|
10731036 | usd |
CY2024Q2 | us-gaap |
Allowance For Doubtful Accounts Receivable Current
AllowanceForDoubtfulAccountsReceivableCurrent
|
988000 | usd |
CY2023Q4 | us-gaap |
Allowance For Doubtful Accounts Receivable Current
AllowanceForDoubtfulAccountsReceivableCurrent
|
1025000 | usd |
CY2024Q2 | us-gaap |
Accounts Receivable Net Current
AccountsReceivableNetCurrent
|
7406272 | usd |
CY2023Q4 | us-gaap |
Accounts Receivable Net Current
AccountsReceivableNetCurrent
|
9706036 | usd |
CY2023Q4 | us-gaap |
Financing Receivable Allowance For Credit Losses
FinancingReceivableAllowanceForCreditLosses
|
1025000 | usd |
us-gaap |
Financing Receivable Allowance For Credit Losses Write Offs
FinancingReceivableAllowanceForCreditLossesWriteOffs
|
37000 | usd | |
CY2024Q2 | us-gaap |
Financing Receivable Allowance For Credit Losses
FinancingReceivableAllowanceForCreditLosses
|
988000 | usd |
CY2024Q2 | us-gaap |
Inventory Raw Materials
InventoryRawMaterials
|
3479654 | usd |
CY2023Q4 | us-gaap |
Inventory Raw Materials
InventoryRawMaterials
|
4785197 | usd |
CY2024Q2 | us-gaap |
Inventory Work In Process
InventoryWorkInProcess
|
1379528 | usd |
CY2023Q4 | us-gaap |
Inventory Work In Process
InventoryWorkInProcess
|
2018421 | usd |
CY2024Q2 | us-gaap |
Inventory Finished Goods
InventoryFinishedGoods
|
790483 | usd |
CY2023Q4 | us-gaap |
Inventory Finished Goods
InventoryFinishedGoods
|
798188 | usd |
CY2024Q2 | us-gaap |
Inventory Net
InventoryNet
|
5649665 | usd |
CY2023Q4 | us-gaap |
Inventory Net
InventoryNet
|
7601806 | usd |
CY2024Q2 | us-gaap |
Antidilutive Securities Excluded From Computation Of Earnings Per Share Amount
AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareAmount
|
5489028 | shares |
CY2023Q3 | us-gaap |
Antidilutive Securities Excluded From Computation Of Earnings Per Share Amount
AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareAmount
|
3989161 | shares |
us-gaap |
Antidilutive Securities Excluded From Computation Of Earnings Per Share Amount
AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareAmount
|
5489028 | shares | |
us-gaap |
Antidilutive Securities Excluded From Computation Of Earnings Per Share Amount
AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareAmount
|
3989161 | shares | |
CY2024Q1 | us-gaap |
Sale Of Stock Number Of Shares Issued In Transaction
SaleOfStockNumberOfSharesIssuedInTransaction
|
3080000 | shares |
CY2024Q1 | KOPN |
Gross Proceeds From Registered Sale Equity Securities
GrossProceedsFromRegisteredSaleEquitySecurities
|
7466755 | usd |
CY2024Q1 | us-gaap |
Shares Issued Price Per Share
SharesIssuedPricePerShare
|
2.42 | |
CY2023Q1 | us-gaap |
Sale Of Stock Number Of Shares Issued In Transaction
SaleOfStockNumberOfSharesIssuedInTransaction
|
17000000 | shares |
CY2023Q4 | us-gaap |
Share Based Compensation Arrangement By Share Based Payment Award Equity Instruments Other Than Options Nonvested Number
ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsNonvestedNumber
|
1931767 | shares |
CY2023Q4 | us-gaap |
Share Based Compensation Arrangement By Share Based Payment Award Equity Instruments Other Than Options Nonvested Weighted Average Grant Date Fair Value
ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsNonvestedWeightedAverageGrantDateFairValue
|
1.65 | |
us-gaap |
Share Based Compensation Arrangement By Share Based Payment Award Equity Instruments Other Than Options Grants In Period
ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsGrantsInPeriod
|
4131820 | shares | |
us-gaap |
Share Based Compensation Arrangement By Share Based Payment Award Equity Instruments Other Than Options Grants In Period Weighted Average Grant Date Fair Value
ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsGrantsInPeriodWeightedAverageGrantDateFairValue
|
1.31 | ||
us-gaap |
Share Based Compensation Arrangement By Share Based Payment Award Equity Instruments Other Than Options Forfeited In Period
ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsForfeitedInPeriod
|
328100 | shares | |
us-gaap |
Share Based Compensation Arrangement By Share Based Payment Award Equity Instruments Other Than Options Forfeitures Weighted Average Grant Date Fair Value
ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsForfeituresWeightedAverageGrantDateFairValue
|
2.70 | ||
us-gaap |
Share Based Compensation Arrangement By Share Based Payment Award Equity Instruments Other Than Options Vested In Period
ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsVestedInPeriod
|
246459 | shares | |
us-gaap |
Share Based Compensation Arrangement By Share Based Payment Award Equity Instruments Other Than Options Vested In Period Weighted Average Grant Date Fair Value
ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsVestedInPeriodWeightedAverageGrantDateFairValue
|
2.00 | ||
CY2024Q2 | us-gaap |
Share Based Compensation Arrangement By Share Based Payment Award Equity Instruments Other Than Options Nonvested Number
ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsNonvestedNumber
|
5489028 | shares |
CY2024Q2 | us-gaap |
Share Based Compensation Arrangement By Share Based Payment Award Equity Instruments Other Than Options Nonvested Weighted Average Grant Date Fair Value
ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsNonvestedWeightedAverageGrantDateFairValue
|
1.32 | |
CY2024Q2 | us-gaap |
Allocated Share Based Compensation Expense
AllocatedShareBasedCompensationExpense
|
676418 | usd |
CY2023Q3 | us-gaap |
Allocated Share Based Compensation Expense
AllocatedShareBasedCompensationExpense
|
1191258 | usd |
us-gaap |
Allocated Share Based Compensation Expense
AllocatedShareBasedCompensationExpense
|
1411346 | usd | |
us-gaap |
Allocated Share Based Compensation Expense
AllocatedShareBasedCompensationExpense
|
1385449 | usd | |
CY2024Q2 | us-gaap |
Allocated Share Based Compensation Expense
AllocatedShareBasedCompensationExpense
|
676418 | usd |
CY2023Q3 | us-gaap |
Allocated Share Based Compensation Expense
AllocatedShareBasedCompensationExpense
|
1191258 | usd |
us-gaap |
Allocated Share Based Compensation Expense
AllocatedShareBasedCompensationExpense
|
1411346 | usd | |
us-gaap |
Allocated Share Based Compensation Expense
AllocatedShareBasedCompensationExpense
|
1385449 | usd | |
CY2024Q2 | us-gaap |
Employee Service Share Based Compensation Nonvested Awards Total Compensation Cost Not Yet Recognized
EmployeeServiceShareBasedCompensationNonvestedAwardsTotalCompensationCostNotYetRecognized
|
7200000 | usd |
us-gaap |
Employee Service Share Based Compensation Nonvested Awards Total Compensation Cost Not Yet Recognized Period For Recognition1
EmployeeServiceShareBasedCompensationNonvestedAwardsTotalCompensationCostNotYetRecognizedPeriodForRecognition1
|
P2Y | ||
us-gaap |
Extended Product Warranty Description
ExtendedProductWarrantyDescription
|
The Company typically warrants its products against defect for 12 to 18 months, however, for certain products a customer may purchase an extended warranty. | ||
CY2023Q4 | us-gaap |
Standard Product Warranty Accrual
StandardProductWarrantyAccrual
|
2160000 | usd |
us-gaap |
Standard Product Warranty Accrual Warranties Issued
StandardProductWarrantyAccrualWarrantiesIssued
|
694000 | usd | |
us-gaap |
Standard Product Warranty Accrual Payments
StandardProductWarrantyAccrualPayments
|
180000 | usd | |
CY2024Q2 | us-gaap |
Standard Product Warranty Accrual
StandardProductWarrantyAccrual
|
2674000 | usd |
CY2024Q2 | us-gaap |
Current Income Tax Expense Benefit
CurrentIncomeTaxExpenseBenefit
|
0.0 | usd |
us-gaap |
Current Income Tax Expense Benefit
CurrentIncomeTaxExpenseBenefit
|
0.0 | usd | |
CY2023Q3 | us-gaap |
Current Income Tax Expense Benefit
CurrentIncomeTaxExpenseBenefit
|
100000 | usd |
us-gaap |
Current Income Tax Expense Benefit
CurrentIncomeTaxExpenseBenefit
|
100000 | usd | |
CY2024Q2 | us-gaap |
Operating Loss Carryforwards
OperatingLossCarryforwards
|
122700000 | usd |
KOPN |
Operating Loss Carryforwards Expiring Date
OperatingLossCarryforwardsExpiringDate
|
expiring 2024 through 2038 | ||
CY2024Q2 | KOPN |
Operating Loss Carryforwards Unlimited
OperatingLossCarryforwardsUnlimited
|
107000000.0 | usd |
CY2024Q2 | us-gaap |
Contract With Customer Asset Net Current
ContractWithCustomerAssetNetCurrent
|
6523002 | usd |
CY2023Q4 | us-gaap |
Contract With Customer Asset Net Current
ContractWithCustomerAssetNetCurrent
|
3409809 | usd |
us-gaap |
Contract With Customer Asset Cumulative Catch Up Adjustment To Revenue Modification Of Contract
ContractWithCustomerAssetCumulativeCatchUpAdjustmentToRevenueModificationOfContract
|
3113193 | usd | |
CY2024Q2 | KOPN |
Percentage Of Change In Contract Assets Current
PercentageOfChangeInContractAssetsCurrent
|
0.91 | pure |
CY2024Q2 | us-gaap |
Contract With Customer Liability Current
ContractWithCustomerLiabilityCurrent
|
198291 | usd |
CY2023Q4 | us-gaap |
Contract With Customer Liability Current
ContractWithCustomerLiabilityCurrent
|
916826 | usd |
KOPN |
Contract With Customer Liability And Billings In Revenue Cumulative Catch Up Adjustment To Revenue Modification Of Contract
ContractWithCustomerLiabilityAndBillingsInRevenueCumulativeCatchUpAdjustmentToRevenueModificationOfContract
|
718535 | usd | |
CY2024Q2 | KOPN |
Percentage Contract Liabilities And Billings In Excess Of Revenue Earned
PercentageContractLiabilitiesAndBillingsInExcessOfRevenueEarned
|
-0.78 | pure |
CY2024Q2 | us-gaap |
Contract With Customer Liability Noncurrent
ContractWithCustomerLiabilityNoncurrent
|
3920 | usd |
CY2023Q4 | us-gaap |
Contract With Customer Liability Noncurrent
ContractWithCustomerLiabilityNoncurrent
|
23198 | usd |
us-gaap |
Contract With Customer Liability Cumulative Catch Up Adjustment To Revenue Modification Of Contract
ContractWithCustomerLiabilityCumulativeCatchUpAdjustmentToRevenueModificationOfContract
|
19278 | usd | |
CY2024Q2 | KOPN |
Percentage Of Change In Contract Liabilitiesnoncurrent
PercentageOfChangeInContractLiabilitiesnoncurrent
|
-0.83 | pure |
CY2024Q2 | KOPN |
Net Contract Assets Liabilities
NetContractAssetsLiabilities
|
6320791 | usd |
CY2023Q4 | KOPN |
Net Contract Assets Liabilities
NetContractAssetsLiabilities
|
2469785 | usd |
KOPN |
Contract With Customer Assets Liability Cumulative Catch Up Adjustment To Revenue Modification Of Contract
ContractWithCustomerAssetsLiabilityCumulativeCatchUpAdjustmentToRevenueModificationOfContract
|
3851006 | usd | |
CY2024Q2 | KOPN |
Percentage Of Change In Net Contract Assets Liabilities
PercentageOfChangeInNetContractAssetsLiabilities
|
1.56 | pure |
CY2024Q2 | KOPN |
Net Contract Assets
NetContractAssets
|
3900000 | usd |
CY2024Q2 | us-gaap |
Contract With Customer Liability Revenue Recognized
ContractWithCustomerLiabilityRevenueRecognized
|
600000 | usd |
us-gaap |
Contract With Customer Liability Revenue Recognized
ContractWithCustomerLiabilityRevenueRecognized
|
900000 | usd | |
CY2023Q3 | us-gaap |
Contract With Customer Liability Revenue Recognized
ContractWithCustomerLiabilityRevenueRecognized
|
100000 | usd |
us-gaap |
Contract With Customer Liability Revenue Recognized
ContractWithCustomerLiabilityRevenueRecognized
|
600000 | usd | |
CY2024Q2 | us-gaap |
Revenue Remaining Performance Obligation
RevenueRemainingPerformanceObligation
|
31600000 | usd |
CY2024Q2 | us-gaap |
Operating Lease Cost
OperatingLeaseCost
|
205743 | usd |
CY2023Q3 | us-gaap |
Operating Lease Cost
OperatingLeaseCost
|
217863 | usd |
us-gaap |
Operating Lease Cost
OperatingLeaseCost
|
433370 | usd | |
us-gaap |
Operating Lease Cost
OperatingLeaseCost
|
432426 | usd | |
CY2024Q2 | us-gaap |
Lessee Operating Lease Liability Payments Remainder Of Fiscal Year
LesseeOperatingLeaseLiabilityPaymentsRemainderOfFiscalYear
|
426743 | usd |
CY2024Q2 | us-gaap |
Lessee Operating Lease Liability Payments Due Next Twelve Months
LesseeOperatingLeaseLiabilityPaymentsDueNextTwelveMonths
|
763994 | usd |
CY2024Q2 | us-gaap |
Lessee Operating Lease Liability Payments Due Year Two
LesseeOperatingLeaseLiabilityPaymentsDueYearTwo
|
732610 | usd |
CY2024Q2 | us-gaap |
Lessee Operating Lease Liability Payments Due Year Three
LesseeOperatingLeaseLiabilityPaymentsDueYearThree
|
669255 | usd |
CY2024Q2 | us-gaap |
Lessee Operating Lease Liability Payments Due Year Four
LesseeOperatingLeaseLiabilityPaymentsDueYearFour
|
201333 | usd |
CY2024Q2 | us-gaap |
Lessee Operating Lease Liability Payments Due
LesseeOperatingLeaseLiabilityPaymentsDue
|
2793935 | usd |
CY2024Q2 | us-gaap |
Lessee Operating Lease Liability Undiscounted Excess Amount
LesseeOperatingLeaseLiabilityUndiscountedExcessAmount
|
335876 | usd |
CY2024Q2 | us-gaap |
Operating Lease Liability
OperatingLeaseLiability
|
2458059 | usd |
CY2024Q2 | us-gaap |
Operating Lease Liability Current
OperatingLeaseLiabilityCurrent
|
672038 | usd |
CY2024Q2 | us-gaap |
Operating Lease Liability Noncurrent
OperatingLeaseLiabilityNoncurrent
|
1786021 | usd |
CY2024Q2 | us-gaap |
Operating Lease Liability
OperatingLeaseLiability
|
2458059 | usd |
us-gaap |
Operating Lease Payments
OperatingLeasePayments
|
432612 | usd | |
us-gaap |
Operating Lease Payments
OperatingLeasePayments
|
496691 | usd | |
CY2024Q2 | us-gaap |
Operating Lease Weighted Average Discount Rate Percent
OperatingLeaseWeightedAverageDiscountRatePercent
|
0.0679 | pure |
CY2023Q3 | us-gaap |
Operating Lease Weighted Average Discount Rate Percent
OperatingLeaseWeightedAverageDiscountRatePercent
|
0.0600 | pure |
CY2024Q2 | us-gaap |
Operating Lease Weighted Average Remaining Lease Term1
OperatingLeaseWeightedAverageRemainingLeaseTerm1
|
P3Y7M6D | |
CY2023Q3 | us-gaap |
Operating Lease Weighted Average Remaining Lease Term1
OperatingLeaseWeightedAverageRemainingLeaseTerm1
|
P4Y3M10D | |
CY2024Q2 | us-gaap |
Noncurrent Assets
NoncurrentAssets
|
4621000 | usd |
CY2023Q4 | us-gaap |
Noncurrent Assets
NoncurrentAssets
|
4668000 | usd |
CY2024Q2 | us-gaap |
Noncurrent Assets
NoncurrentAssets
|
4621000 | usd |
CY2023Q4 | us-gaap |
Noncurrent Assets
NoncurrentAssets
|
4668000 | usd |
CY2024Q2 | us-gaap |
Revenue From Contract With Customer Excluding Assessed Tax
RevenueFromContractWithCustomerExcludingAssessedTax
|
12336000 | usd |
CY2024Q2 | KOPN |
Percentage Of Total Revenue
PercentageOfTotalRevenue
|
1 | pure |
CY2023Q3 | us-gaap |
Revenue From Contract With Customer Excluding Assessed Tax
RevenueFromContractWithCustomerExcludingAssessedTax
|
10460000 | usd |
CY2023Q3 | KOPN |
Percentage Of Total Revenue
PercentageOfTotalRevenue
|
1 | pure |
us-gaap |
Revenue From Contract With Customer Excluding Assessed Tax
RevenueFromContractWithCustomerExcludingAssessedTax
|
22369000 | usd | |
KOPN |
Percentage Of Total Revenue
PercentageOfTotalRevenue
|
1 | pure | |
us-gaap |
Revenue From Contract With Customer Excluding Assessed Tax
RevenueFromContractWithCustomerExcludingAssessedTax
|
21218000 | usd | |
KOPN |
Percentage Of Total Revenue
PercentageOfTotalRevenue
|
1 | pure | |
CY2024Q2 | us-gaap |
Revenue From Contract With Customer Excluding Assessed Tax
RevenueFromContractWithCustomerExcludingAssessedTax
|
12336000 | usd |
CY2023Q3 | us-gaap |
Revenue From Contract With Customer Excluding Assessed Tax
RevenueFromContractWithCustomerExcludingAssessedTax
|
10460000 | usd |
us-gaap |
Revenue From Contract With Customer Excluding Assessed Tax
RevenueFromContractWithCustomerExcludingAssessedTax
|
22369000 | usd | |
us-gaap |
Revenue From Contract With Customer Excluding Assessed Tax
RevenueFromContractWithCustomerExcludingAssessedTax
|
21218000 | usd | |
CY2024Q2 | us-gaap |
Loss Contingency Damages Sought
LossContingencyDamagesSought
|
On Monday, April 22, 2024, after a four week trial, a jury verdict was entered finding for BlueRadios and awarding approximately $5.1 million in damages as well as recommending $19.7 million in disgorgement and exemplary damages. While no final judgment has been issued by the Court, the Court will take that recommendation under advisement and will rule in its final judgment on the final amount after briefing on the issues. | |
CY2024Q2 | us-gaap |
Loss Contingency Accrual At Carrying Value
LossContingencyAccrualAtCarryingValue
|
10000000 | usd |
CY2024Q2 | us-gaap |
Payments For Fees
PaymentsForFees
|
10000000 | usd |
us-gaap |
Loss Contingency Damages Sought Value
LossContingencyDamagesSoughtValue
|
5100000 | usd | |
KOPN |
Loss Contingency Exemplary Damages Sought Value
LossContingencyExemplaryDamagesSoughtValue
|
19700000 | usd | |
CY2024Q2 | us-gaap |
Revenues
Revenues
|
234323 | usd |
CY2024Q2 | us-gaap |
Related Party Transaction Purchases From Related Party
RelatedPartyTransactionPurchasesFromRelatedParty
|
97305 | usd |
CY2023Q3 | us-gaap |
Revenues
Revenues
|
798901 | usd |
CY2023Q3 | us-gaap |
Related Party Transaction Purchases From Related Party
RelatedPartyTransactionPurchasesFromRelatedParty
|
168800 | usd |
us-gaap |
Revenues
Revenues
|
441633 | usd | |
us-gaap |
Related Party Transaction Purchases From Related Party
RelatedPartyTransactionPurchasesFromRelatedParty
|
186655 | usd | |
us-gaap |
Revenues
Revenues
|
1272401 | usd | |
us-gaap |
Related Party Transaction Purchases From Related Party
RelatedPartyTransactionPurchasesFromRelatedParty
|
208055 | usd | |
CY2024Q2 | us-gaap |
Accounts Receivable Net
AccountsReceivableNet
|
231999 | usd |
CY2024Q2 | us-gaap |
Accounts Payable Current And Noncurrent
AccountsPayableCurrentAndNoncurrent
|
64155 | usd |
CY2023Q4 | us-gaap |
Accounts Receivable Net
AccountsReceivableNet
|
144915 | usd |
CY2023Q4 | us-gaap |
Accounts Payable Current And Noncurrent
AccountsPayableCurrentAndNoncurrent
|
97600 | usd |